10 mg: Rivaroxaban is indicated for the prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery. Rivaroxaban is indicated for the treatment of Deep Vein Thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE.
15 mg/20 mg: Rivaroxaban is indicated for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (SPAF).
Rivaroxaban is indicated for the treatment of Deep Vein Thrombosis (DVT) and for the prevention of recurrent DVT and Pulmonary Embolism (PE).
Rivaroxaban is indicated for the treatment of Pulmonary Embolism (PE) and for the prevention of recurrent PE and DVT.
Other Services
Country
Account